This Review discusses the current treatment of the manifestations of primary Sjögren syndrome and summarizes ongoing clinical trials. The authors examine the status of biologic therapies, the challenges relating to clinical trial design and potential targets for the future therapies.
- Alain Saraux
- Jacques-Olivier Pers
- Valérie Devauchelle-Pensec